Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: Cross-sectional study

British Journal of Psychiatry

Volumn 200, Issue 5, 2012, Pages 381-386

  Nicholson, Timothy R J ^a   Ferdinando, Sumudu ^b   Krishnaiah, Ravikumar B ^c   Anhoury, Sophie ^a   Lennox, Belinda R ^d   Mataix Cols, David ^a   Cleare, Anthony ^a   Veale, David M ^a   Drummond, Lynne M ^b   Fineberg, Naomi A ^c   Church, Andrew J ^e   Giovannoni, Gavin ^f   Heyman, Isobel ^g  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b South West London and St George's NHS Trust St George's ^*  (United Kingdom)

^c QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOLASE C; ANTIBODY; ANTISTREPTOLYSIN; BASAL GANGLIA ANTIBODY; ENOLASE; PYRUVATE KINASE; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BASAL GANGLION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; RISK FACTOR; SCHIZOPHRENIA; STREPTOCOCCUS INFECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS; BASAL GANGLIA; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84860570315     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.092007     Document Type: Article

References (40)

1. Radua J, Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 2009; 195: 393-402.
2. de Koning PP, Figee M, van den Munckhof P, Schuurman PR, Denys D. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiatry Rep 2011; 13: 274-82.
3. Guehl D, Benazzouz A, Aouizerate B, Cuny E, Rotge JY, Rougier A, et al. Neuronal correlates of obsessions in the caudate nucleus. Biol Psychiatry 2008; 63: 557-62. (Pubitemid 351284469)
4. Cavedini P, Gorini A, Bellodi L. Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol Rev 2006; 16: 3-15. (Pubitemid 43954074)
5. Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010; 27: 495-506.
6. Asbahr FR, Negrao AB, Gentil V, Zanetta DM, da Paz JA, Marques-Dias MJ, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998; 155: 1122-4. (Pubitemid 28357745)
7. Martino D, Giovannoni G. Antibasal ganglia antibodies and their relevance to movement disorders. Curr Opin Neurol 2004; 17: 425-32. (Pubitemid 39071418)
8. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002; 59: 227-31. (Pubitemid 34779182)
9. Edwards MJ, Trikouli E, Martino D, Bozi M, Dale RC, Church AJ, et al. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. Neurology 2004; 63: 156-8. (Pubitemid 38943796)
10. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003; 74: 602-7.
11. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127: 21-33. (Pubitemid 38055343)
12. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-71. (Pubitemid 28074291)
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
14. Dale RC, Heyman I, Giovannoni G, Church AWJ. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 2005; 187: 314-9. (Pubitemid 41442381)
15. Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess 2002; 14: 485-96. (Pubitemid 35440493)
16. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-11. (Pubitemid 19278229)
17. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9. (Pubitemid 9136500)
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (suppl 20): 22-33. (Pubitemid 29001829)
19. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006; 172: 187-97. (Pubitemid 43277505)
20. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 911-7. (Pubitemid 27274532)
21. Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 1532-42.
22. Morer A, Lazaro L, Sabater L, Massana J, Castro J, Graus F. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J Psychiatr Res 2008; 42: 64-8. (Pubitemid 47562433)
23. Gause C, Morris C, Vernekar S, Pardo-Villamizar C, Grados MA, Singer HS. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol 2009; 214: 118-24.
24. Maina G, Albert U, Bogetto F, Borghese C, Berro AC, Mutani R, et al. Anti-brain antibodies in adult patients with obsessive-compulsive disorder. J Affect Disord 2009; 116: 192-200.
25. Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK. Anti-brain autoantibodies and altered excitatory neuro-transmitters in obsessive-compulsive disorder. Neuropsychopharmacology 2009; 34: 2489-96.
26. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 2006; 39: 21-9. (Pubitemid 43878517)
27. Kansy JW, Katsovich L, McIver KS, Pick J, Zabriskie JB, Lombroso PJ, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 2006; 181: 165-76. (Pubitemid 44827293)
28. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 2010; 20: 317-31.
29. Martino D, Church A, Giovannoni G. Are antibasal ganglia antibodies important, and clinically useful? Pract Neurol 2007; 7: 32-41. (Pubitemid 46231604)
30. Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41: 123-32. (Pubitemid 351372294)
31. Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 2007; 12 (suppl 3): 14-27.
32. Yaddanapudi K, Hornig M, Serge R, De Miranda J, Baghban A, Villar G, et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 2010; 15: 712-26.
33. Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010; 50: 481-90.
34. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354: 1153-8. (Pubitemid 29460444)
35. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005; 57: 788-92. (Pubitemid 40487923)
36. Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999; 45: 1564-71. (Pubitemid 29292832)
37. Storch EA, Murphy TK, Geffken GR, Mann G, Adkins J, Merlo LJ, et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry 2006; 45: 1171-8.
38. de Oliveira SK, Pelajo CF. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep 2010; 12: 103-9.
39. Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686-8.
40. Brilot F, Merheb V, Ding A, Murphy T, Dale RC. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011; 76: 1508-13.